TipRanks
Advertisement
Advertisement
Pacific Biosciences: Buy Rating Reaffirmed with Unchanged $3 Price Target Amid Temporary Headwinds and Long-Term Growth Drivers
PremiumRatingsPacific Biosciences: Buy Rating Reaffirmed with Unchanged $3 Price Target Amid Temporary Headwinds and Long-Term Growth Drivers
2M ago
Pacific Biosciences Earnings Call: Growth Amid Headwinds
Premium
Company Announcements
Pacific Biosciences Earnings Call: Growth Amid Headwinds
3M ago
PacBio CEO Christian Henry steps down, Mark Van Oene succeeds
Premium
The Fly
PacBio CEO Christian Henry steps down, Mark Van Oene succeeds
3M ago
Pacific Biosciences Announces Resignation of Board Member
PremiumCompany AnnouncementsPacific Biosciences Announces Resignation of Board Member
4M ago
Pacific Biosciences Shareholders Approve Governance and Compensation Measures
Premium
Company Announcements
Pacific Biosciences Shareholders Approve Governance and Compensation Measures
5M ago
PacBio announces SPRQ-Nx chemistry now shipping worldwide
Premium
The Fly
PacBio announces SPRQ-Nx chemistry now shipping worldwide
5M ago
Pacific Biosciences Balances Growth Hopes and Margin Strain
PremiumCompany AnnouncementsPacific Biosciences Balances Growth Hopes and Margin Strain
6M ago
PacBio reports Q1 EPS (12c), consensus (13c)
Premium
The Fly
PacBio reports Q1 EPS (12c), consensus (13c)
6M ago
PacBio sees FY26 revenue $165M-$175M, consensus $174.42M
Premium
The Fly
PacBio sees FY26 revenue $165M-$175M, consensus $174.42M
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―